Arrowstreet Capital, Limited Partnership Corcept Therapeutics Inc Call Options Transaction History
Arrowstreet Capital, Limited Partnership
- $114 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CORT
# of Institutions
337Shares Held
87.5MCall Options Held
1.08MPut Options Held
852K-
Black Rock Inc. New York, NY16.5MShares$934 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$565 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.24MShares$465 Million11.51% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$367 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$215 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.05B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...